Sartorius (SRT3) Given a €76.00 Price Target at Commerzbank

Commerzbank set a €76.00 ($90.48) target price on Sartorius (FRA:SRT3) in a research report sent to investors on Wednesday. The brokerage currently has a neutral rating on the stock.

Several other research firms also recently issued reports on SRT3. UBS Group set a €85.00 ($101.19) target price on Sartorius and gave the company a neutral rating in a research report on Tuesday, October 17th. Deutsche Bank set a €80.00 ($95.24) target price on Sartorius and gave the company a neutral rating in a research report on Friday, December 1st. Nord/LB set a €70.00 ($83.33) target price on Sartorius and gave the company a sell rating in a research report on Tuesday, October 17th. Warburg Research set a €100.00 ($119.05) target price on Sartorius and gave the company a buy rating in a research report on Tuesday, October 17th. Finally, Berenberg Bank set a €90.00 ($107.14) target price on Sartorius and gave the company a buy rating in a research report on Wednesday, September 20th. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. Sartorius presently has an average rating of Hold and an average price target of €78.40 ($93.33).

Sartorius (SRT3) opened at €88.00 ($104.76) on Wednesday. Sartorius has a 12-month low of €63.72 ($75.86) and a 12-month high of €94.00 ($111.90). The stock has a market capitalization of $6,450.00 and a price-to-earnings ratio of 71.54.

COPYRIGHT VIOLATION NOTICE: This report was published by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at https://transcriptdaily.com/2018/01/14/sartorius-srt3-given-a-76-00-price-target-at-commerzbank.html.

Sartorius Company Profile

Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply